Live Breaking News & Updates on Cstone Pharmaceuticals
Stay updated with breaking news from Cstone pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CStone Pharmaceuticals (HK:2616) has released an update. CStone Pharmaceuticals recently presented promising data from their phase 1a/1b study of C. ....
CStone's Sugemalimab Poised for European Approval biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
SUZHOU, China, June 2, 2024 /PRNewswire/ — CStone Pharmaceuticals (HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and… ....
CStone Pharmaceuticals (HK:2616) has released an update. CStone Pharmaceuticals has published promising preliminary data from a phase 1a/1b study o. ....
CS5001 is the first known ROR1 antibody-drug conjugate (ADC) to demonstrate clinical anti-tumor activity in both solid tumors and lymphomas, and among the top two globally in clinical development. First-in-human study data show that CS5001 is well tolerated with promising anti-tumor activity at various dose levels in heavily pretreated, advanced solid tumors and lymphomas. Dose escalation in the. ....